LYEL - Lyell Immunopharma Inc
22.46
0.410 1.825%
Share volume: 42,370
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$22.05
0.41
0.02%
Summary score
42%
Profitability
35%
Dept financing
22%
Liquidity
58%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.76%
Return on assets
-9.94%
Return on sales
-612383.06%
Return on invested capital
-22.92%
Total debt ratio
15.11%
Debt ratio change over timeo
-1.94%
Current Ratio
14.33%
Quick Ratio
16.21%
Cash Position Ratio
10.52%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-21.48%
Return on sales
-965497%
Return on invested capital
0%
Total debt ratio
21.01%
Debt ratio change over timeo
0%
Current Ratio
8.28%
Quick Ratio
0%
Cash Position Ratio
2.92%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-10.32%
Return on sales
-248353.33%
Return on invested capital
0%
Total debt ratio
19.33%
Debt ratio change over time
0%
Current Ratio
10.3%
Quick Ratio
0%
Cash Position Ratio
3.88%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-38.14%
Return on assets
-49.81%
Return on sales
3776987.02%
Return on invested capital
114.17%
Total debt ratio
-194.03%
Debt ratio change over time
-1.94%
Current Ratio
-134.81%
Quick Ratio
-146.76%
Cash Position Ratio
-127.71%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LYEL | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -6.76% | 13.23% | 9.84% | 26.17% |
| Return on assets | -9.94% | 4.59% | 3.2% | 1.81% |
| Return on sales | -612383.06% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | -22.92% | 8.51% | 10.28% | 4.83% |
| Profitability | 0% | 83% | 73% | 67% |
| Total debt ratio | 15.11% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | -1.94% | -16.59% | -73.52% | 21.11% |
| Dept financing | 4% | 22% | 16% | 50% |
| Current Ratio | 8.28% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 2.92% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 4% | 5% | 3% |
| Short-term ratios | LYEL | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -21.48% | 5.82% | 4.08% | 0.78% |
| Return on sales | -965497% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 13% |
| Total debt ratio | 21.01% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 30% | 20% | 15% | 25% |
| Current Ratio | 8.28% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 2.92% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 30% | 28% | 18% |